Alberto A. Mendivil, MD

 

Alberto A. Mendivil, MD FACOG, FACS completed his undergraduate study in Animal Physiology and Neurosciences at the University of California, San Diego before receiving his medical degree at the University of Utah School of Medicine.  Dr. Mendivil’s internship and residency training in Obstetrics and Gynecology was at the University of California, Irvine.  His Fellowship training in Gynecologic Oncology was completed at the University of North Carolina, Chapel Hill.

Download and Print New Patient Forms

 

 

 

Business Address
Gynecologic Oncology Associates
351 Hospital Road, Suite 507
Newport Beach, CA 92663
Ph. 949-642-1361
Fax 949-642-1394
amendivil@gynoncology.com

________________________________________________________________________

PERSONAL:

Foreign language: Spanish (speak, read, and write)

________________________________________________________________________

PROFESSIONAL TRAINING:

Fellowship

Gynecologic Oncology
Department of Obstetrics and Gynecology
University of North Carolina, Chapel Hill
CB# 7572
Chapel Hill, NC 27599-7572
PH: 919-966-5996
FAX: 919-843-5387
Fellowship Program Director: John F. Boggess, MD
July 1, 2007 to June 30, 2010

Internship/ Residency
Department of Obstetrics and Gynecology
University of California, Irvine Medical Center
101 The City Drive, Bldg 56, Suite 800
Orange, CA 92868
PH: 714-456-8224
Residency Program Director: Carol A. Major, MD
June 23, 2003 to June 22, 2007
_______________________________________________________________________

BOARD CERTIFICATION:

America Board of Obstetrics and Gynecology
General Obstetrics and Gynecology, 12/2009

American Board of Obstetrics and Gynecology
Gynecologic Oncology, 4/13

________________________________________________________________________

EDUCATION:

Medical School

University of Utah School of Medicine
Date of Graduation: May 24, 2003
-Degree: M.D.

Undergraduate

University of California, San Diego
Date of Graduation: June 14, 1998
-Degree: Bachelor of Science
-Major: Animal Physiology and Neurosciences
-Minor: Health Care/ Social Issues

________________________________________________________________________

PEER REVIEWED PUBLICATIONS:

Mendivil AA, Goldstein BH. Reply: Radical Hysterectomy and Survival Outcomes in the Management of Early Stage Cervical Cancer Surgical Oncology. Surg Oncol 2016; 25: 123.

Mendivil AA, Rettenmaier MA, Abaid LN, Brown JV 3rd, Micha JP, Lopez KL, Goldstein BH. Survival rate comparisons amongst cervical cancer patients treated with an open, robotic-assisted or laparoscopic radical hysterectomy: A five year experience. Surg Oncol 2016; 25: 66-71.

Micha JP, Rettenmaier MA, Brown III JV, Mendivil AA, Abaid LN, Lopez KL, Goldstein BH. A randomized, controlled pilot study comparing the impact of aprepitant and fosaprepitant on chemotherapy induced nausea and vomiting in patients treated for gynecologic cancer. Int J Gynecol Cancer. 2016; 26:389-393.

Rettenmaier MA, Abaid LN, Brown JV 3rd, Mendivil AA, Lopez KL, Goldstein BH. Dramatically reduced incidence of vaginal cuff dehiscence in gynecologic patients undergoing endoscopic closure with barbed sutures: A retrospective cohort study. Int J Surg 2015; 19:27-30.

Rettenmaier MA, Mendivil AA, Abaid LN, Brown JV 3rd, Micha JP, Wilcox AM, Goldstein BH.
The feasibility of administering varying high-dose consolidation hyperthermic intraperitoneal chemotherapy with carboplatin in the treatment of ovarian carcinoma
Arch Gynecol Obstet 2015; 291:1381-6.

Rettenmaier MA, Mendivil AA, Gray CM, Chapman AP, Stone MK, Tinnerman EJ, Goldstein BH. Intra-abdominal temperature distribution during consolidation hyperthermic intraperitoneal chemotherapy with carboplatin in the treatment of advanced stage ovarian carcinoma. Int J Hyperthermia 2015; 24:1-7.

Mendivil AA, Rettenmaier MA, Abaid LN, Brown JV 3rd, Micha JP, Lopez KL, Goldstein BH. A comparison of open surgery, robotic-assisted surgery and conventional laparoscopic surgery in the treatment of morbidly obese endometrial cancer patients. JSLS 2015;19: 1-5.

Rettenmaier MA, Mendivil AA, Abaid LN, Brown JV, Wilcox AM, Goldstein BH. Consolidation Hyperthermic Intraperitoneal Chemotherapy and Maintenance Chemotherapy Following Laparoscopic Cytoreductive Surgery in the Treatment of Advanced Stage Ovarian Carcinoma. Int J Hyperthermia 2015;31:8-14.

Brown JV, Mendivil AA, Abaid LN, Rettenmaier MA, Micha JP, Wabe MA, Goldstein BH. The Safety and Feasibility of Robotic Lymph Node Staging in Early-Stage Ovarian Cancer. Int J Gynecol Cancer 24(8) 2014.

Rettenmaier MA, Abaid LN, Brown JV 3rd, Mendivil AA, Micha JP, Goldstein BH. The incidence of postprandial nausea and nutritional regression in gynecologic cancer patients following intestinal surgery: A retrospective cohort study. Int J Surg 2014; 12: 783-787.

Mendivil AA, Micha JP, Stallman JM, Goldstein BH. A Very Rare Case of Vaginal Angiokeratoma. Euro J Gynaecol Oncol 2014; 3: 313-315.

Mendivil AA, Brown III JV, Abaid LN, Rettenmaier MA, Micha JP, Wabe MA, Goldstein BH. Robotic-Assisted Surgery for the Treatment of Pelvic Masses in Pregnant Patients: A Series of Four Cases and Literature Review.J Robot Surg 2013; 7: 333–337. Care 2013; 2: 124.

Mendivil AA, Cupp JS, Van Dalsem W, Caffarelli A, Goldstein BH. Multidisciplinary treatment of pelvic and cardiac intravenous leiomyosarcomatosis. Gynecol Oncol 2013; 6: 16–18.

LN, Micha JP, Rettenmaier MA, Brown JV, Mendivil AA, Lopez KL, Goldstein BH. A phase II study of modified dose-dense paclitaxel and every 4-week carboplatin for the treatment of advanced-stage primary epithelial ovarian, fallopian tube, or peritoneal carcinoma. Cancer Chemother Pharmacol 2013;72:101-107.

Micha JP, Brown JV, Rettenmaier MA, Abaid LN, Mendivil AA, Lopez KI, Goldstein BH. Pegfilgrastim safely administered on the same day as dose-dense chemotherapy for patients with advanced-stage ovarian cancer. Clin Oncol 2013; Feb (letter).

Mendivil AA, Micha JP, Brown JV 3rd, Rettenmaier MA, Abaid LN, Lopez KL, Goldstein BH. Increased incidence of severe gastrointestinal events with first-line Paclitaxel, Carboplatin, and Vorinostat chemotherapy for advanced-stage epithelial ovarian, primary peritoneal, and fallopian tube cancer. Int J Gynecol Cancer 2013;23:533-9.

Mendivil AA, Stallman JM, Chad JN, Goldstein BH. An Unusual Case of Fallopian IntraepithelialTube Carcinoma with Mucinous Goblet Cell Differentiation. Gynecol Oncol 2012; 2: 47-50.

Micha JP, Mendivil AA, Cupp JS, Goldstein BH. Recurrent Lymphatic Ascites in a Patient Cured of CervicalCarcinoma. Gyn Oncol 2012; 2: 105-106.

Mendivil AA, Abaid L, Epstein HD, Rettenmaier MA, Brown JV 3rd, Micha JP, Wabe MA, Goldstein BH. Paget’s disease of the vulva: a clinicopathologic institutional review. Int J Clin Oncol 2012; 17:569-74.

Rettenmaier MA, Mendivil AA, Brown JV III, Abaid LN, Micha JP, Goldstein BH. Same Day Discharge in Clinical Stage 1 Endometrial Cancer Patients Treated with Total Laparoscopic Hysterectomy, Bilateral Salpingoophorectomy and Bilateral Pelvic Lymphadenectomy. Oncol 2012;82:321-326

Abaid LN, Rettenmaier MA, Brown III JV, Micha JP, Mendivil AA, Wabe MA, Goldstein BH. Sequential chemotherapy and radiotherapy as sandwich therapy for the treatment of high risk endometrial cancer.  J Gynecol Oncol 2012; 23: 22-27.

Mendivil AA, Abaid LN, Epstein HD, Rettenmaier MA, Brown JV III, Micha JP, Wabe MA, Goldstein BH. Paget’s Disease of the Vulva: A Clinicopathologic Institutional Review. Int J Clin Oncol 2012; 17:569-74.

Mendivil A, Rettenmaier MA, Cox C, Abaid LA, Brown JV, Micha JP, Lopez KL, Goldstein BH. Acute and Delayed Complications from Surgery and Adjuvant Radiotherapy in the Treatment of High Risk Endometrial and Cervical Cancer. 2011 Oncology, 81:79-83.

Micha JP, Mendivil A, Epstein HD,  LaFlamme LA, Goldstein BH. An Unusual Case of Endometrioid Adenocarcinoma Arising from Endometriosis. 2011 J Repro Med, manuscript accepted for publication.

Mendivil A, Zhou C, Cantrell LA, Gehrig PA, Mallory KM, Bae-Jump VL. AMG 479, a novel IGF-1-R antibody, inhibits endometrial cancer cell proliferation through disruption of the PI3K/Akt and MAPK pathways. 2011 Repro Sci, manuscript accepted for publication.

Cantrell LA, Mendivil A, Gehrig PA, Boggess JF. Survival Outcomes for Women Undergoing Type III Robotic Radical Hysterectomy for Cervical Cancer: A 3-year experience. 2010 Gynecol Oncol, 117(2):260-5.

Cantrell LA, Zhou C, Mendivil A, Gehrig PA, Malloy KM, Bae-Jump VL. Metformin is a potent inhibitor of endometrial cancer cell proliferation – implications for a novel treatment strategy. 2009 Gyncol Oncol, 116(1): 92-98.

Boggess JF, Gehrig PA, Cantrell LA, Shafer A, Mendivil A, Rossi E, Hanna R. Perioperative outcomes of robotically assisted hysterectomy for benign cases with complex pathology. 2009 Obstet Gynecol, 114(3).

Mendivil A, Holloway RW, Boggess JF. Invited Review: Emergence of robotic assisted surgery in gynecologic oncology: American perspective. 2009 Gynecol Oncol, 114(2): S24-S31.

Mendivil A, Schuler KM, Gehrig PA. Invited Review: Non-Endometrioid adenocarcinoma of the uterine corpus: a review of selected histological subtypes. 2009 Cancer Control, 16(1): 46-52.

Gehrig PA, Cantrell LA, Shafer A, Abaid LN, Mendivil A, Boggess JF. What is the optimal minimally invasive surgical procedure for endometrial cancer staging in the obese and morbidly obese woman? 2008 Gynecol Oncol, 111(1): 41-45.

Yessaian A, Mendivil A, Brewster WR. Population characteristics in cervical cancer trials: Search for external validity. 2005 Am J Obstet Gynecol, 192(2): 407-13.

La Cava A, Massa M, Mendivil A, Martini A, Albani S. Genetic Immunization Maps T Cell (Auto) Immune Responses to Self Antigens Homologous to Exogenous Proteins. 2002 Autoimmunity, 35(2): 105-10.

Prakken B, Wauben M, Genini D, Samodal R, Barnett J, Mendivil A, Leoni L, Albani S. Artificial antigen-presenting cells as a tool to exploit the immune ‘synapse’. 2000 Nature Medicine, 6(12): 1406-10.

BOOK CHAPTERS:

Mendivil A, Boggess JF. Robotic Surgery in Gynecologic Oncology. In: Textbook in Gynaecologic Oncology (ESGO ENYGO Endorsed). Edited by Ayhan, Gultekin, Dursun. Publisher: Gunes Kıtabevleri, 2011.

Mendivil A, Fowler WC. Early epithelial ovarian cancer. In: Gynecological Cancer Management: Identification, Diagnosis, and Treatment. D Clarke-Pearson, JT Soper (eds) 2009. Publisher: Wiley-Blackwell, 2010

Mendivil A, Bae-Jump VL. Germ cell tumors. In: Gynecological Cancer Management: Identification, Diagnosis, and Treatment. D Clarke-Pearson, JT Soper (eds) 2009. Publisher: Wiley-Blackwell, 2010

Mendivil A, Clarke-Pearson D. Gynecological Cancer Management: Identification, Diagnosis, and Treatment. D Clarke-Pearson, JT Soper (eds) 2009. Publisher: Wiley-Blackwell, 2010

Mendivil A, Boggess JF. Robotic Surgery in Gynecologic Oncology. In: Textbook in Gynaecologic Oncology (ESGO ENYGO Endorsed). Edited by Ayhan, Gultekin, Dursun. Publisher: Gunes Kıtabevleri, 2009

________________________________________________________________________

ORAL PRESENTATIONS:

BRCA and the Hereditary Breast/ Ovarian Cancer Syndrome.  Grand Rounds presented at Nash Regional Medical Center, Rocky Mount, NC, April 14, 2009.

Gynecologic Surgery in the Obese Patient. Grand Rounds presented at the New Hanover Regional Medical Center, Wilmington, NC, March 6, 2009.

Robotic Surgery Training in Gynecologic Oncology: A Comparison of Fellow and Attending Surgical Times. Presented at the 40th Annual Meeting of the Society of Gynecologic Oncologists, San Antonio, TX, February 5, 2009.

A Three-Year Analysis of Endometrial Cancer Staging via Robotic Assistance. Presented at the 2nd Annual Meeting of the International Gynecologic Oncology Robotics Symposium, Chapel Hill, NC, November 10, 2008.

A Fellow and Attending Surgeon Comparison of Robotic Surgical Outcomes in A Fellowship Training Program. Presented at the 2nd Annual Meeting of the International Gynecologic Oncology Robotics Symposium, Chapel Hill, NC, November 10, 2008.

Metformin’s Effects on Endometrial Cancer. Presented at the 23rd Annual Meeting of the Mid-Atlantic Gynecologic Oncology Society, Washington, DC, September 20, 2008.

Growth of Robotic Surgery Among Gynecologic Oncologists. Presented at the 23rd Annual Meeting of the Mid-Atlantic Gynecologic Oncology Society, Washington, DC, September 20, 2008.

Management of Primary Peritoneal and Fallopian Tube Carcinomas: Are they similar to Epithelial Ovarian Cancer?  25th Annual Philip J. DiSaia Resident Paper Day.  UCI Department of Obstetrics and Gynecology. Orange, CA. May 12, 2007.

Absence of Cardiotoxicity with Long-Term Use of Pegylated Liposomal Doxorubicin in Recurrent Ovarian Cancer.  24th Annual Philip J. DiSaia Resident Paper Day.  UCI Department of Obstetrics and Gynecology. Costa Mesa, CA. May 19, 2006.

________________________________________________________________________

RESEARCH/ POSTER PRESENTATIONS:

Micha JP, Rettenmaier MA, Brown III JV, Mendivil AA, Abaid LN, Lopez KL, Goldstein BH. A phase IV, randomized study comparing the impact of aprepitant and fosaprepitant on chemotherapy induced nausea and vomiting and activities of daily living in patients treated for gynecologic cancer. European Society of Gynaecological Oncology Annual Meeting; October 2015: Nice, FR.

MA, Mendivil AA, Abaid LN, Brown III JV, Micha JP, Wilcox AM, Goldstein BH. Consolidation Hyperthermic Intraperitoneal Chemotherapy and Maintenance Chemotherapy FollowingLaparoscopic Cytoreductive Surgery in the Treatment of Ovarian Carcinoma. International Gynecologic Cancer Society Annual Meeting; May 2015: Santiago, CL.

Rettenmaier MA, Abaid LN, Brown JV III, Micha JP, Lopez KL, Goldstein BH. A Comparison of Open Surgery, Robotic-Assisted Surgery and Conventional Laparoscopic Surgery in the Treatment of Morbidly Obese Endometrial Cancer Patients. ESJO Annual Meeting; October 2013: Liverpool, UK.

Abaid LN, Micha JP, Rettenmaier MA, Brown JV, Mendivil AA, Lopez KL,  Goldstein BH. A Phase II Study of Modified Dose-Dense Paclitaxel and Every 4 week Carboplatin for the Treatment of Advanced Stage Primary Epithelial Ovarian, Fallopian Tube, or PeritonealCarcinoma. March 2012 Society of Gynecologic Oncology Meeting, Austin, TX.

Mendivil A, Zhou C, Cantrell LA, Gehrig PA, Malloy KM, and Bae-Jump VL: Rapamycin potentiates the effects of paclitaxel in uterine papillary serous carcinoma (UPSC) cells through inhibition of cell proliferation and induction of apoptosis. Abstract presented at the Annual meeting of the American Association for Cancer Research, Washington, DC, April 2010.

O’Malley DM, Achenbach S, Skaznik-Wikiel M, Nakayama JM, Mendivil A, Havrilesky LJ, Secord AA, DeBernardo R, Gehrig PA, Fader AN: Improved survival with chemotherapy and radiation in advanced-stage uterine clear cell carcinoma. Abstract presented at the Annual Meeting of the Society of Gynecologic Oncologists, San Francisco, CA, March 2010.

O’Malley DM, Nakayma J, Secord AA, DeBernardo R, Gehrig PA, Fader AN, Mendivil A, Cohn DE, Skaznik-Wikiel M, Havrilesky L: Benefit of Adjuvant Therapy in Early Stage Clear Cell Cancer of the Uterus? Abstract presented at the Annual Meeting of the Society of Gynecologic Oncologists, San Francisco, CA, March 2010.

Mendivil A, Vogel TJ, Gehrig PA: A survival comparison between women with uterine serous and/or clear cell carcinoma with and without a history of breast cancer. Abstract presented at the Annual Meeting of the American Society of Clinical Oncology, Orlando, FL, May 2009.

Mendivil A, Zhou C, Cantrell LA, Gehrig PA, Malloy KM, Bae-Jump VL: AMG 479, a novel IGF-1R antibody, inhibits endometrial cancer cell proliferation through disruption of the PI3K/Akt and MAPK pathways. Abstract presented at the Annual Meeting of the American Association for Cancer Research, Denver, CO, April 2009.

Mendivil A, Zhou C, Cantrell LA, Gehrig PA, Malloy KM, Bae-Jump VL: AMG 479, a novel IGF-1R antibody, inhibits endometrial cancer cell proliferation through disruption of the PI3K/Akt and MAPK pathways. Abstract presented at the Annual UNC Women’s Health Research Day Conference, Chapel Hill, NC, April 2009.

Mendivil A, Cantrell LA, Gehrig PA, Boggess JF: Survival Outcomes for Women Undergoing Robotic Surgery for Endometrial Cancer: A Three-Year Experience. Abstract presented at the Annual Meeting of the Society of Gynecologic Oncologists, San Antonio, TX, February 2009.

Cantrell LA, Mendivil A, Zhou C, Gehrig PA, Bae-Jump VL: Metformin is a potent inhibitor of endometrial cancer cell proliferation- implications for a novel treatment strategy. Abstract presented at the 40th Annual Meeting of the Society of Gynecologic Oncologists, San Antonio, TX, February 2009.

Cantrell LA, Mendivil A, Gehrig PA, Boggess JF: Survival Outcomes for Women Undergoing Robotic Surgery for Cervical Cancer: A Three-Year Experience. Abstract presented at the 40th Annual Meeting of the Society of Gynecologic Oncologists, San Antonio, TX, February 2009.

Hanna R, Cantrell LA, Gehrig PA, Mendivil A, Boggess JF: A cost analysis of robotic as compared to conventional laparoscopy for endometrial cancer staging. Abstract presented at the 40th Annual Meeting of the Society of Gynecologic Oncologists, San Antonio, TX, February 2009.

Boggess JF, Shafer A, Cantrell LA, Abaid L, Mendivil A, Gehrig PA: Robotically Assisted Type III Radical Hysterectomy in a Morbidly Obese Woman. Abstract at the 39th Annual Meeting of the Society of Gynecologic Oncologists, Tampa Bay, FL, March 2008.

Mendivil A, Hunter MI, Han E, Tewari KS: Management Of Primary Peritoneal And Fallopian Tube Carcinomas In The Platinate-Taxane Era.  Abstract at the 39th Annual Meeting of the Society of Gynecologic Oncologists, Tampa Bay, FL, March 2008.

Gehrig PA, Cantrell LA, Shafer A,  Abaid L, Mendivil A, Boggess JF: What is the optimal minimally invasive surgical procedure for endometrial cancer staging in the obese and morbidly obese woman?  Abstract at the 39th Annual Meeting of the Society of Gynecologic Oncologists, Tampa Bay, FL, March 2008.

Hunter MI, Ziogas A, Mendivil A, Brewster WR:  Second primary breast cancer after epithelial ovarian cancer and tumors of low malignant potential.  Abstract at the 39th Annual Meeting of the Society for Gynecologic Investigation, Los Angeles, CA, April 2005.

Mendivil A, Cole BC, Sawitzke A: Mapping B-cell epitopes on mycoplasma arthritidis mitogen (MAM) using lambda phage display peptide library.  Abstract at the Western Student Medical Research Forum, Deer Valley, UT, February 2001.

Prakken B, Samodal R, Mendivil A, Bonnin D, Lanza P, Amox D, Roord S, DeKleer I, Jones M, Carson D, Albani S.  An E. coli Heat Shock Protein dnaJ Peptide Homologous To The “Shared Epitope” Is A Trigger Of Pro-Inflammatory, TH-1 Type T Cell Responses In Patients With Early Rheumatoid Arthritis (RA).  Abstract at the Annual Meeting of the American College of Rheumatology, San Diego, CA, May 1998.

Samodal R, Louie S, Amox D, Bonnin D, Yang X, Weaver B, Mendivil A, Prakken B, Carson D, Albani S. Immunomodulatory Effects Of Treatment With A “Shared Epitope” Peptide In Patients With Rheumatoid Arthritis. Abstract at the Annual Meeting of the American College of Rheumatology, San Diego, CA, May 1998.

________________________________________________________________________
LEADERSHIP:

Administrative Chief Resident, UCI Medical Center, Dept. of OB/GYN, 2006-2007

ACOG Junior Fellow District IX, Section 7 Chair, 2005-2006

‘Life of Medicine’ undergraduate course co-instructor, UC Irvine, 2005

Student Body Co-President, University of Utah School of Medicine, 2002-2003

Student Advisory Committee, Department of Obstetrics and Gynecology, University of Utah School of Medicine, 2001

Association of Minority Medical Students, University of Utah School of Medicine Co-President, 1999-2000

National Medical Fellowships, Academy Fellow, University of Utah School of Medicine Representative, 2001-2002

2nd Year Class Co-President, University of Utah School of Medicine, 2000-2001

Executive Committee member, University of Utah School of Medicine, 2000-2001, 2002-2003

Alumni Association Board Member, University of Utah School of Medicine, 2000-2001, 2002-2003

Community Outreach Program Student Coordinator, University of Utah School of Medicine, 2000-2001

International Pharmacy Student Foundation Book Appeal Project, 2000

-Book drive organizing committee chairman (medical school section)

-Over 600 medical books were collected and donated to Cruz Roja Mexicana Hospital, Tijuana, Mexico

Medical Spanish Instructor- University of Utah School of Medicine, 1999-2001

________________________________________________________________________

AWARDS:

Best Fellow Presentation, Annual Meeting of the Mid-Atlantic Gynecologic Oncology Society, September, 2008

Philip J. DiSaia, MD UCI Medical Student Teaching Award, June 2007

UCI School of Medicine Resident Teaching Award, June 2007

UCI School of Medicine Resident Teaching Award, June 2005

UCI Dept. of OB/Gyn 2ND Year Resident Teaching Award, June 2005

UCI Dept. of OB/Gyn Teaching Resident of the Month, July 2004

UCI Dept. of Internal Medicine Outpatient Clinic Resident of the Month, July 2003

University of Utah School of Medicine Alumni Association Student Award, 2003

Bristol-Myers Squibb/ NMF Academic Medicine Research Fellowship, 2002

Linda Derrick Wood Scholarship, 2002

The Endocrine Society Research Fellowship, 2002

Herbert W. Nickens, M.D. Minority Medical Student Scholarship, 2001

National Medical Fellowships, Inc. Scholarship, 2001

Western Student Medical Research Award, 2001

Robert Wood Johnson Foundation Award, 2000-2001

Edward C. Klatt, M.D. Scholarship, 2000-2001

Bristol-Myers Squibb/ NMF Academic Medicine Fellowship (Finalist), 2000

Summer Institute for Medical Students, Betty Ford Center, Scholarship, 2000

National Medical Fellowships, Inc. Scholarship, 2000

Medical Student Research Fellowship, U of Utah School of Medicine, 2000

Dean A. Moffat, M.D. Memorial Scholarship, 1999-2000

Bernett Love Memorial Scholarship, 1999-2000

Undergraduate Research Scholar, University of California, San Diego, 1997

Howard Hughes Research Stipend, University of California, San Diego, 1997

Academic Grant, University of California, San Diego, 1993-1994

David Holmgren Memorial Scholarship, 1993

________________________________________________________________________

PROFESSIONAL ASSOCIATIONS:

American Association of Gynecologic Laparoscopy
Center of Excellence in Minimally Invasive Gynecologic Surgery
Surgeon Designee (2012)

Orange County California Medical Association, 2003-2007

Mid-Atlantic Gynecologic Oncology Society, 2008-present

Society of Gynecologic Oncologists, Fellow-in-training, 2007-present

American College of Surgeons, Resident-in-training, 2008-present

American College of Obstetricians and Gynecologists, Junior Fellow, 2004-present

National Hispanic Medical Association, 2000-2003